| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.1B | $6.1B | $5.8B | $5.1B | $4.2B | $3.7B | $3.4B | $3.1B |
| Cost of Revenue | $1.6B | $1.2B | $1.2B | $1.1B | $0.9B | $0.8B | $0.8B | $0.7B |
| Gross Profit | $5.4B | $4.9B | $4.6B | $4.0B | $3.3B | $2.9B | $2.6B | $2.4B |
| R&D Expense | $2.5B | $2.1B | $1.9B | $1.7B | $1.5B | $1.3B | $1.1B | $1.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $1.4B | $1.3B | $1.2B | $0.7B | $0.6B | $0.5B | $0.4B |
| Net Income | $1.3B | $2.3B | $1.2B | $1.0B | $0.8B | $0.7B | $0.5B | $0.4B |
| EPS (Basic) | $8.13 | $14.78 | $8.08 | $6.44 | $4.96 | $4.40 | $3.55 | $2.90 |
| EPS (Diluted) | $8.04 | $14.51 | $7.92 | $6.29 | $4.81 | $4.27 | $3.45 | $2.82 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $48.2B | $13.1B | $10.3B | $9.4B | $8.8B | $8.0B | $6.4B | $6.1B |
| Current Assets | $6.0B | $6.5B | $3.4B | $3.0B | $2.8B | $2.5B | $1.7B | $1.5B |
| Cash & Equivalents | $2.9B | $3.9B | $1.4B | $1.4B | $1.4B | $1.2B | $0.7B | $0.7B |
| Total Liabilities | $19.9B | $4.1B | $4.1B | $3.9B | $3.5B | $3.1B | $2.3B | $2.7B |
| Current Liabilities | $3.7B | $2.7B | $3.0B | $2.8B | $2.4B | $2.1B | $1.8B | $2.1B |
| Stockholders' Equity | $28.3B | $9.0B | $6.1B | $5.5B | $5.3B | $4.9B | $4.1B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.4B | $1.7B | $1.7B | $1.5B | $1.0B | $0.8B | — |
| Investing Cash Flow | $-15.9B | $1.2B | $-0.5B | $-0.6B | $-0.5B | $-0.4B | $-0.2B | — |
| Capital Expenditures | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $13.4B | $-0.2B | $-1.2B | $-1.1B | $-0.7B | $-0.1B | $-0.6B | — |